<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="cause" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="contrast" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">1. Introduction</segment>
<segment id="2" parent="1002" relname="preparation">Cancer is one of the most important and deadly diseases worldwide .</segment>
<segment id="3" parent="4" relname="attribution">Reports from the World Health Organization show</segment>
<segment id="4" parent="1003" relname="span">that almost 1 in 6 deaths worldwide in 2018 were due to cancer .</segment>
<segment id="5" parent="1002" relname="joint">Chemotherapy is a common approach for cancer treatment ;</segment>
<segment id="6" parent="1006" relname="span">it uses drugs</segment>
<segment id="7" parent="6" relname="purpose">to kill cancer cells .</segment>
<segment id="8" parent="1009" relname="span">However , various limitations affect the efficiency of chemotherapy .</segment>
<segment id="9" parent="1010" relname="joint">For example , most chemotherapeutics possess poor aqueous solubility ,</segment>
<segment id="10" parent="1011" relname="span">harm normal cell toxicity</segment>
<segment id="11" parent="1012" relname="joint">due to the lack of selectivity ,</segment>
<segment id="12" parent="1012" relname="joint">and cause multidrug resistance .</segment>
<segment id="13" parent="1013" relname="span">To handle these shortcomings ,</segment>
<segment id="14" parent="1014" relname="span">researchers have proposed nano-particles as novel drug carriers</segment>
<segment id="15" parent="14" relname="purpose">to help patients cope with cancer .</segment>
<segment id="16" parent="1002" relname="joint">Nanoparticles , like vesicles , nanotubes , micelles , nanofibers , and nanosheet are typically commonly formed by amphiphilic copolymers via self-assembly .</segment>
<segment id="17" parent="1018" relname="span">Nanoparticles can encapsulate drugs via physical entrapment or solubilization</segment>
<segment id="18" parent="17" relname="purpose">to achieve various advantages ,</segment>
<segment id="19" parent="1018" relname="elaboration">including controlled drug release , decreased cytotoxicity , increased aqueous solubility , and targeted action site .</segment>
<segment id="20" parent="1020" relname="span">Thus , nanoparticles have opened the door</segment>
<segment id="21" parent="1021" relname="joint">for developing effective drug delivery schemes</segment>
<segment id="22" parent="1021" relname="joint">and have shown substantial potential for applications in life-threatening disease treatments , such as cancer therapy .</segment>
<segment id="23" parent="1024" relname="span">Chemotherapy usually causes a decline in immunity ,</segment>
<segment id="24" parent="1025" relname="contrast">causing cancer patients to suffer from bacterial infection</segment>
<segment id="25" parent="1025" relname="contrast">or threatening their lives .</segment>
<segment id="26" parent="1022" relname="joint">Therefore , avoiding bacterial infection is essential during cancer therapy .</segment>
<segment id="27" parent="1029" relname="span">As a kind of novel antibacterial agent , antimicrobial peptides</segment>
<segment id="28" parent="27" relname="restatement">( AMPs )</segment>
<segment id="29" parent="1028" relname="same_unit">have gained increasing attention over the past few decades .</segment>
<segment id="30" parent="1030" relname="span">AMPs exhibit excellent antibacterial capability and a unique antibacterial mechanism .</segment>
<segment id="31" parent="1031" relname="span">AMPs achieve their bactericidal effect</segment>
<segment id="32" parent="33" relname="concession">by physical disruption of bacterial membranes ;</segment>
<segment id="33" parent="1032" relname="span">however , inducing bacterial drug resistance presents difficulty .</segment>
<segment id="34" parent="1035" relname="attribution">Research illustrates</segment>
<segment id="35" parent="1035" relname="span">that such a unique antibacterial mechanism is relevant to specific AMP structures ,</segment>
<segment id="36" parent="35" relname="elaboration">including cationic moieties such as lysine and hydrophobic moieties such as phenylalanine .</segment>
<segment id="37" parent="38" relname="concession">Lots of AMPs are amphiphilic peptides ,</segment>
<segment id="38" parent="1037" relname="span">namely , they are composed of hydrophobic and hydrophilic residues .</segment>
<segment id="39" parent="1022" relname="joint">AMP-nanoparticles can be prepared in an aqueous solution through self-assembly of these AMPs .</segment>
<segment id="40" parent="1040" relname="span">AMP assemblies are ideal drug delivery systems</segment>
<segment id="41" parent="40" relname="elaboration">exhibiting both drug release and antibacterial capabilities during cancer treatment .</segment>
<segment id="42" parent="1042" relname="span">Our group has reported several amphiphilic block AMPs</segment>
<segment id="43" parent="42" relname="elaboration">containing lysine and phenylalanine .</segment>
<segment id="44" parent="1022" relname="joint">These AMPs exhibit high bactericidal efficiency and low cytotoxicity .</segment>
<segment id="45" parent="1047" relname="span">Vesicles</segment>
<segment id="46" parent="45" relname="elaboration">formed by these AMPs have good performance</segment>
<segment id="47" parent="1047" relname="circumstance">when carrying drugs .</segment>
<segment id="48" parent="1048" relname="contrast">Motivated by the excellent properties and promising applications of AMP nanoparticles ,</segment>
<segment id="49" parent="1048" relname="contrast">synthetic amphiphilic AMP – mimetic polymers are proposed .</segment>
<segment id="50" parent="1050" relname="span">These amphiphilic copolymers stimulate the structural features of AMPs ,</segment>
<segment id="51" parent="50" relname="elaboration">that is , cationic and hydrophobic moieties .</segment>
<segment id="52" parent="1053" relname="span">Amphiphilic copolymers not only possess good properties , such as a unique bactericidal mechanism , the capability for self-assembly into nanoparticles</segment>
<segment id="53" parent="52" relname="elaboration">that are similar to those of natural AMPs ,</segment>
<segment id="54" parent="1022" relname="joint">but also show more convenient synthesis strategy than natural AMPs .</segment>
<segment id="55" parent="1056" relname="attribution">In previous work , Zhou et al. have reported</segment>
<segment id="56" parent="1057" relname="span">the minimal inhibition concentration</segment>
<segment id="57" parent="56" relname="restatement">( MIC )</segment>
<segment id="58" parent="1056" relname="same_unit">of amphiphilic copolymers was less than 32 μg/mL against both Gram-negative and Gram-positive bacteria .</segment>
<segment id="59" parent="1059" relname="span">The broad antibacterial capability has been proved ,</segment>
<segment id="60" parent="59" relname="elaboration">which will play a vital role in cancer therapy .</segment>
<segment id="61" parent="1061" relname="span">In our previous work , a series of amphiphilic mimicked AMP copolymers , PCL16- b -Kn ,</segment>
<segment id="62" parent="61" relname="elaboration">which can inhibit both Gram-negative and Gram-positive bacteria .</segment>
<segment id="63" parent="1063" relname="preparation">In the present work , we studied the self-assembling behavior of these block copolymers in aqueous solutions .</segment>
<segment id="64" parent="1065" relname="span">The morphologies and sizes of nanoparticles were characterized by transmission electron microscopy</segment>
<segment id="65" parent="64" relname="restatement">( TEM )</segment>
<segment id="66" parent="1066" relname="span">and dynamic light scattering</segment>
<segment id="67" parent="66" relname="elaboration">( DLS ) , respectively .</segment>
<segment id="68" parent="1069" relname="span">Critical vesiculation concentrations</segment>
<segment id="69" parent="68" relname="restatement">( CVCs )</segment>
<segment id="70" parent="1068" relname="same_unit">were also studied .</segment>
<segment id="71" parent="1071" relname="span">Drug delivery potential was investigated by in vitro and intracellular doxorubicin</segment>
<segment id="72" parent="71" relname="elaboration">( DOX)-release experiments .</segment>
<segment id="73" parent="1072" relname="span">Based on the results , amphiphilic diblock copolymers PCL16- b -Kn could serve as efficient drug carriers for cancer treatment .</segment>
<segment id="74" parent="1073" relname="span">Given the excellent antibacterial properties and low cytotoxicity of PCL16- b -Kn</segment>
<segment id="75" parent="74" relname="elaboration">in previous works , such diblock copolymer nanoparticles can be ideal “ armed ” drug delivery systems for applications in nanomedical fields .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="multinuc" parent="1001" relname="span"/>
<group id="1003" type="span" parent="1002" relname="joint"/>
<group id="1006" type="span" parent="1002" relname="joint"/>
<group id="1008" type="span" parent="1002" relname="joint"/>
<group id="1009" type="span" parent="1008" relname="span"/>
<group id="1010" type="multinuc" parent="8" relname="elaboration"/>
<group id="1011" type="span" parent="1010" relname="joint"/>
<group id="1012" type="multinuc" parent="10" relname="cause"/>
<group id="1013" type="span" parent="1009" relname="purpose"/>
<group id="1014" type="span" parent="13" relname="elaboration"/>
<group id="1017" type="span" parent="1002" relname="joint"/>
<group id="1018" type="span" parent="1017" relname="span"/>
<group id="1019" type="multinuc" parent="1002" relname="joint"/>
<group id="1020" type="span" parent="1019" relname="sequence"/>
<group id="1021" type="multinuc" parent="20" relname="purpose"/>
<group id="1022" type="multinuc" parent="1019" relname="sequence"/>
<group id="1024" type="span" parent="1022" relname="joint"/>
<group id="1025" type="multinuc" parent="23" relname="elaboration"/>
<group id="1028" type="multinuc" parent="1022" relname="joint"/>
<group id="1029" type="span" parent="1028" relname="same_unit"/>
<group id="1030" type="span" parent="1022" relname="joint"/>
<group id="1031" type="span" parent="30" relname="elaboration"/>
<group id="1032" type="span" parent="31" relname="elaboration"/>
<group id="1034" type="span" parent="1022" relname="joint"/>
<group id="1035" type="span" parent="1034" relname="span"/>
<group id="1037" type="span" parent="1022" relname="joint"/>
<group id="1040" type="span" parent="1022" relname="joint"/>
<group id="1042" type="span" parent="1022" relname="joint"/>
<group id="1045" type="span" parent="1022" relname="joint"/>
<group id="1046" type="span" parent="1045" relname="span"/>
<group id="1047" type="span" parent="1046" relname="span"/>
<group id="1048" type="multinuc" parent="1046" relname="elaboration"/>
<group id="1050" type="span" parent="1022" relname="joint"/>
<group id="1053" type="span" parent="1022" relname="joint"/>
<group id="1055" type="span" parent="1022" relname="joint"/>
<group id="1056" type="multinuc" parent="1055" relname="span"/>
<group id="1057" type="span" parent="1056" relname="same_unit"/>
<group id="1059" type="span" parent="1022" relname="joint"/>
<group id="1061" type="span" parent="1022" relname="joint"/>
<group id="1062" type="span" parent="1022" relname="joint"/>
<group id="1063" type="multinuc" parent="1062" relname="span"/>
<group id="1064" type="multinuc" parent="1063" relname="joint"/>
<group id="1065" type="span" parent="1064" relname="same_unit"/>
<group id="1066" type="span" parent="1064" relname="same_unit"/>
<group id="1068" type="multinuc" parent="1063" relname="joint"/>
<group id="1069" type="span" parent="1068" relname="same_unit"/>
<group id="1070" type="span" parent="1063" relname="joint"/>
<group id="1071" type="span" parent="1070" relname="span"/>
<group id="1072" type="span" parent="1071" relname="elaboration"/>
<group id="1073" type="span" parent="73" relname="elaboration"/>
	</body>
</rst>
